Fully Automated Pipeline for the Detection and Segmentation of Non-Small Cell Lung Cancer (NSCLC) on CT Images
Fully Automated Pipeline for the Detection and Segmentation of Non-Small Cell Lung Cancer (NSCLC) on CT Images: Quantitative and Qualitative Evaluation
Sponsor: Affiliated Zhongshan Hospital of Dalian University, 6 Jiefang street, Dalian 116001, China
This observational or N/A phase trial investigates Detection and Segmentation and is currently ongoing. Affiliated Zhongshan Hospital of Dalian University, 6 Jiefang street, Dalian 116001, China leads this study, which shows 7 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jan 2022 — Jul 2024 [monthly]
Unknown Status
Status: Active Not Recruiting → Unknown Status
-
Oct 2021 — Jan 2022 [monthly]
Active Not Recruiting
-
Jan 2021 — Oct 2021 [monthly]
Active Not Recruiting
▶ Show 2 earlier versions
-
May 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Dec 2019 — May 2020 [monthly]
Active Not Recruiting
First recorded
Mar 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Affiliated Zhongshan Hospital of Dalian University, 6 Jiefang street, Dalian 116001, China
- Centre Hospitalier Universitaire de Liege
- Maastricht University
- University Hospital RWTH Aachen University, Aachen, Germany.
- University of California, San Francisco
For direct contact, visit the study record on ClinicalTrials.gov .